Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: Kevin McKenzie who wrote (11395)	11/15/1998 12:12:00 AM
From: JEB	Respond to of 119973

CTII and GERN are doing wonders for my BGEN stock!

To: Kevin McKenzie who wrote (11395)	11/15/1998 12:31:00 AM
From: wallacestevens	Read Replies (1) \| Respond to of 119973

To: Kevin McKenzie who wrote (11395)	11/15/1998 11:49:00 PM
From: Gregg Sterner	Read Replies (1) \| Respond to of 119973

This should nail CTII's lid shut tight....... A Quote from their Nov. 11 Press Release...... ---------------------------------------------------------- CytoTherapeutics does not have any revenues from commercial products and finances its operations through the sale of stock and partnership agreements with large pharmaceutical companies. In 1995, for example, it signed a deal with Astra AB, a Swiss pharmaceutical company, to help pay for its work in encapsulated cell technology. Rose is currently looking for a partner to help finance the stem cell research. "We need a partner," said Rose. "These are large markets and the cost for moving into them is substantial. I've been working on this very hard for a year. We're at the last stages of the dance." By William J. Donovan